09.08.2012
- Denmark's Novo Nordisk hiked its full-year sales and profit targets after rising demand for diabetes drug Victoza and insulins helped the company beat second-quarter expectations...
27.04.2012
- Danish drugmaker Novo Nordisk said it expected its U.S. insulin market share to improve and edged up its full-year targets after stiff competition for insulin and disappointing...
